Literature DB >> 9404741

Cigarette smoking and histologic type of lung cancer in men.

F Barbone1, M Bovenzi, F Cavallieri, G Stanta.   

Abstract

STUDY
OBJECTIVES: To determine whether intensity, duration, age at initiation, and cessation of cigarette smoking act differently in the development of various histologic types of lung cancer.
DESIGN: A case-control study among deceased men who underwent autopsy, a procedure that involves approximately 73% of all local deaths.
SETTING: The Province of Trieste in northeastern Italy PARTICIPANTS: Seven hundred fifty-five patients with lung cancer, including 267 with squamous cell carcinoma, 218 with small cell carcinoma, 90 with large cell carcinoma, 158 with adenocarcinoma, and 22 with other histologic types, and 755 control subjects who had died of causes other than chronic lung diseases and certain tumors. Information on smoking habits, residential history, and occupational exposure was obtained from each subject's next of kin.
RESULTS: Compared with nonsmokers, the odds ratio (OR) for current smokers was 13.4 for all types combined, 18.8 for squamous cell carcinoma, 14.3 for small cell carcinoma, 34.3 for large cell carcinoma, and 7.9 for adenocarcinoma. Intensity of smoking, duration, age at starting, and dose were all directly associated with all histologic types of lung cancer, although the OR was lower for adenocarcinoma than for other cell types. When results were restricted to ever smokers, exposure-response curves were similar across histologic types. The risk of lung cancer attributable to smoking was 88% for all types combined, 91% for squamous cell carcinoma, 89% for small cell carcinoma, 95% for large cell carcinoma, and 82% for adenocarcinoma.
CONCLUSIONS: This study confirms that cigarette smoking causes all types of lung cancer, but the proportion of cases attributable to smoking is lower for adenocarcinoma than for other types, due to a higher proportion of nonsmokers.

Entities:  

Mesh:

Year:  1997        PMID: 9404741     DOI: 10.1378/chest.112.6.1474

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  34 in total

Review 1.  [Updated strategies in Small Cell Lung Cancer post ASCO 2007].

Authors:  Stefan Hoschek; Ursula Hoschek-Risslegger; Michael Fiegl; August Zabernigg; Georg Pall; Thomas Auberger; Eberhard Gunsilius; Thomas Schmid; Herbert Jamnig; Wolfgang Hilbe
Journal:  Wien Med Wochenschr       Date:  2007

2.  Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study.

Authors:  Pamela M McMahon; Chung Yin Kong; Bruce E Johnson; Milton C Weinstein; Jane C Weeks; Karen M Kuntz; Jo-Anne O Shepard; Stephen J Swensen; G Scott Gazelle
Journal:  Radiology       Date:  2008-05-05       Impact factor: 11.105

Review 3.  Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer.

Authors:  Peter N Lee; Barbara A Forey; Katharine J Coombs
Journal:  BMC Cancer       Date:  2012-09-03       Impact factor: 4.430

Review 4.  Mitochondrial toxicity of tobacco smoke and air pollution.

Authors:  Jessica L Fetterman; Melissa J Sammy; Scott W Ballinger
Journal:  Toxicology       Date:  2017-08-22       Impact factor: 4.221

Review 5.  Treatment of advanced squamous cell carcinoma of the lung: a review.

Authors:  Benjamin A Derman; Kathryn F Mileham; Philip D Bonomi; Marta Batus; Mary J Fidler
Journal:  Transl Lung Cancer Res       Date:  2015-10

6.  Differences in trends of lung carcinoma by histology type in Israeli Jews and Arabs, 1981-1995.

Authors:  O Baron-Epel; H Andreev; M Barhana; M S Green
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

Review 7.  [Small cell lung cancer].

Authors:  Stefan Hoschek; Ursula Hoschek-Risslegger; Michael Fiegl; August Zabernigg; Georg Pall; Thomas Auberger; Eberhard Gunsilius; Thomas Schmid; Herbert Jamnig; Wolfgang Hilbe
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

8.  Risks of second primary cancer among patients with major histological types of lung cancers in both men and women.

Authors:  S-C Chuang; G Scélo; Y-C A Lee; S Friis; E Pukkala; D H Brewster; K Hemminki; E Tracey; E Weiderpass; S Tamaro; V Pompe-Kirn; E V Kliewer; K-S Chia; J M Tonita; C Martos; J G Jonasson; P Boffetta; P Brennan; M Hashibe
Journal:  Br J Cancer       Date:  2010-03-30       Impact factor: 7.640

9.  A small-cell lung cancer genome with complex signatures of tobacco exposure.

Authors:  Erin D Pleasance; Philip J Stephens; Sarah O'Meara; David J McBride; Alison Meynert; David Jones; Meng-Lay Lin; David Beare; King Wai Lau; Chris Greenman; Ignacio Varela; Serena Nik-Zainal; Helen R Davies; Gonzalo R Ordoñez; Laura J Mudie; Calli Latimer; Sarah Edkins; Lucy Stebbings; Lina Chen; Mingming Jia; Catherine Leroy; John Marshall; Andrew Menzies; Adam Butler; Jon W Teague; Jonathon Mangion; Yongming A Sun; Stephen F McLaughlin; Heather E Peckham; Eric F Tsung; Gina L Costa; Clarence C Lee; John D Minna; Adi Gazdar; Ewan Birney; Michael D Rhodes; Kevin J McKernan; Michael R Stratton; P Andrew Futreal; Peter J Campbell
Journal:  Nature       Date:  2009-12-16       Impact factor: 49.962

10.  MUTYH Gln324His gene polymorphism and genetic susceptibility for lung cancer in a Japanese population.

Authors:  Aiko Miyaishi; Kayo Osawa; Yasunori Osawa; Natsuko Inoue; Kana Yoshida; Mayumi Kasahara; Akimitsu Tsutou; Yoshiki Tabuchi; Kazuo Sakamoto; Noriaki Tsubota; Juro Takahashi
Journal:  J Exp Clin Cancer Res       Date:  2009-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.